安哲, 李思鹏, 张妮, 李妙羡, 王香玲. 抗HBs在HBV既往感染中的临床价值[J]. 实用预防医学, 2016, 23(5): 621-623.
AN Zhe, LI Si-peng, ZHANG Ni, LI Miao-xian, WANG Xiang-ling. Clinical Value of AntiHBs for previous Hepatitis B Virus Infection. , 2016, 23(5): 621-623.
[1] 中华医学会肝病学分会中华医学会感染病分会. 慢性乙型肝炎防治指南(2010年版)[J]. 中国病毒病杂志, 2011,1(1): 9-23. [2] 骆抗先. 乙型肝炎基础和临床[M]. 第3版. 北京：人民卫生出版社,2006：246-247. [3] Ponde RA, Cardoso DD, Ferro MO. The underlying mechanisms for the “ant-HBc alone” serological profile[J]. Arch Virol, 2010, 155:149-158. [4] BHIVA Hepatitis and immunization Guidelines http://www.bhiva.org/HepBC2010.aspx. [5] Gandhi RT, Wurcel A, Lee H, et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies[J]. J Infect Dis, 2005, 191:1435-1441. [6] Guillermo M, Anna L, Alberto L, et al. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice[J]. Vaccine, 2012, 30:3703-3709. [7] S. Pallawela, C. Sonnex, D. Mabayoje et.al. Positive Hepatitis B Virus Core Antibody in HIV Infection - False Positive or Evidence of Previous Infection [J]. Journal of Medical Virology, 2015, 87(2):208-212. http://onlinelibrary.wiley.com/doi/10.1002/jmv.24048/pdf. [8] 林伟研, 倪进东, 唐豪, 等. Th17细胞因子IL-17A与乙肝疫苗无/弱应答关联的研究[J].实用预防医学, 2014,（08）:904-905+899.
2016, Vol. 23 
